scispace - formally typeset
Y

Yaomei Wang

Researcher at Zhengzhou University

Publications -  16
Citations -  517

Yaomei Wang is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Erythropoiesis & Medicine. The author has an hindex of 6, co-authored 10 publications receiving 320 citations. Previous affiliations of Yaomei Wang include New York Blood Center.

Papers
More filters
Journal ArticleDOI

Intrinsic Immunity Shapes Viral Resistance of Stem Cells

TL;DR: It is shown that intrinsically expressed ISGs protect stem cells against viral infection, demonstrating the in vivo importance of intrinsic ISG expression for protecting stem cells and their differentiation potential during viral infection.
Journal ArticleDOI

Distinct roles for TET family proteins in regulating human erythropoiesis

TL;DR: It is shown here that TET2 and TET3 but not TET1 are expressed in human erythroid cells, and the role of these proteins in erythropoiesis is explored, to provide new insights into their role in regulating human ERYthroid differentiation at distinct stages of development.
Journal ArticleDOI

TET2 deficiency leads to stem cell factor-dependent clonal expansion of dysfunctional erythroid progenitors

TL;DR: It is shown that TET2 deficiency leads initially to stem cell factor-dependent hyperproliferation and impaired differentiation of human colony-forming unit-erythroid (CFU-E) cells, which were reversed by a c-Kit inhibitor, and previously unknown mechanisms by which deficiency of TET1 contributes to ineffective erythropoiesis are uncovered.
Journal ArticleDOI

SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS

TL;DR: It is Documented that SF3B1 knockdown in human CD34+ cells leads to increased apoptosis and cell cycle arrest of early-stage erythroid cells and generation of abnormally nucleated late-Stage erythroblasts and these findings have implications for improved understanding of ineffective erythropoiesis in MDS patients with SF3 B1 mutations.